PRMT6 and central nervous system cancer: Then, we investigated the prognostic significance of PRMT6 expression in patients with glioma, and the results showed that patients with high levels of PRMT6 had poorer overall survival compared to those with low PRMT6 expression (Fig. 1C, G).